# Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease

> **NCT02335281** · PHASE2 · UNKNOWN · sponsor: **Yanling Wei** · enrollment: 40 (estimated)

## Conditions studied

- Inflammatory Bowel Disease
- Ulcerative Colitis
- Crohn's Disease

## Interventions

- **PROCEDURE:** FMT
- **DRUG:** Mesalazine

## Key facts

- **NCT ID:** NCT02335281
- **Lead sponsor:** Yanling Wei
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2017-10
- **Final completion:** 2017-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2015-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02335281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02335281, "Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02335281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*